Condition
Crush Injury
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Completed2
Recruiting1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06003166Phase 2Recruiting
4-AP Peripheral Nerve Crossover Trial
NCT07094165Not ApplicableCompleted
The Effects of Dexmedetomidine and Remifentanil on Kidney Injury After Muscle Compression Injury in Rats
NCT06310265Completed
Our Anesthesia Experiment Applied to Child Earthquake Victims in the February 6, 2023 Earthquake
NCT04049721Not ApplicableWithdrawnPrimary
Use of Hyperbaric Oxygen Therapy for the Treatment of Crush Injuries
Showing all 4 trials